Core Laboratories (CLB) Shares Outstanding (Weighted Average) (2022 - 2026)

Core Laboratories has reported Shares Outstanding (Weighted Average) for 5 years, with the latest figure at $46.1 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 1.5% year-over-year to $46.1 million; the trailing twelve-month figure through Mar 2026 stood at $46.1 million (down 1.5% YoY), and the FY2025 full-year result was $46.4 million, down 1.0% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $46.1 million, down from $46.4 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $46.9 million in Q3 2024, with the low at $46.1 million in Q1 2026.
• Historically, Shares Outstanding (Weighted Average) has averaged $46.6 million across 5 years, with a median of $46.7 million in 2023.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) grew 0.81% — and 2026, when it dropped 1.5%.
• Core Laboratories' Shares Outstanding (Weighted Average) stood at $46.3 million in 2022, then climbed by 0.75% to $46.7 million in 2023, then rose by 0.46% to $46.9 million in 2024, then retreated by 1.0% to $46.4 million in 2025, then decreased by 0.76% to $46.1 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $46.1 million (Q1 2026), $46.4 million (Q4 2025), and $46.3 million (Q3 2025), per Business Quant data.